NeuroStar, developed by Neuronetics, Inc., is the first transcranial magnetic stimulation (TMS) device to receive Breakthrough Device Designation for bipolar depression MALVERN, Pa., March 06, 2020 ...

NeuroStar Advanced Therapy for Mental Health is a transcranial magnetic stimulation system that uses magnetic fields to reignite dormant synapses in the brain. The Food and Drug Administration (FDA) ...

NeuroStar Advanced Therapy is a transcranial magnetic stimulation system that uses magnetic fields to induce neural activity in the cerebral cortex. The Food and Drug Administration (FDA) has cleared ...

Transcranial magnetic stimulation pioneer Neuronetics has picked up a new FDA clearance that builds its position in obsessive-compulsive disorder (OCD), a major new application of the technology.

EAST WHITELAND >> A Malvern area company that has been making inroads with its non-drug treatment for depression announced an agreement with a Japanese firm that should increase its use there.

The US Food and Drug Administration (FDA) has granted breakthrough device designation for NeuroStar Advanced Therapy (Neuronetics Inc) transcranial magnetic stimulation (TMS) system for the treatment ...

Neuronetics, Inc., a medical technology company focused on mental health, has announced key updates regarding its NeuroStar therapy. The company will be a Silver Sponsor at the 13th Annual Clinical ...

The US Food and Drug Administration (FDA) has cleared the next-generation NeuroStar Advanced Therapy transcranial magnetic stimulation (TMS) device for patients with treatment-resistant major ...

MALVERN, Pa., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life ...

Neuronetics Inc., of Malvern, Pa., has won U.S. FDA breakthrough device designation for its Neurostar transcranial magnetic stimulation device for the treatment of patients with drug-resistant bipolar ...

MALVERN, Pa., March 06, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the ...